CompuGroup Medical SE & Co KgaA
XETRA:COP

Watchlist Manager
CompuGroup Medical SE & Co KgaA Logo
CompuGroup Medical SE & Co KgaA
XETRA:COP
Watchlist
Price: 21.7 EUR -0.18% Market Closed
Market Cap: 1.1B EUR
Have any thoughts about
CompuGroup Medical SE & Co KgaA?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

138.4m
-15%
Operating Cash Flow
Growth Rates:
1 Year
-28%
3 Years
-16%
5 Years
-18%
7 Years
+72%
10 Years
+172%
-123.2m
-23%
Investing Cash Flow
Growth Rates:
1 Year
+1%
3 Years
+76%
5 Years
-55%
7 Years
-148%
10 Years
-18%
3.3m
Financing Cash Flow
Growth Rates:
1 Year
-
3 Years
-96%
5 Years
-
7 Years
-
10 Years
-94%

Cash Flow Statement
CompuGroup Medical SE & Co KgaA

Rotate your device to view
Cash Flow Statement
Currency: EUR
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
21
26
24
40
38
32
39
27
36
41
44
47
46
41
32
36
53
65
93
99
82
83
66
55
61
77
73
72
73
66
69
76
71
72
74
70
89
77
47
51
33
Depreciation & Amortization
42
42
43
43
44
44
45
45
46
45
44
43
42
40
38
39
39
42
45
49
53
58
63
65
67
71
76
86
93
102
111
111
113
114
112
111
111
110
116
116
118
Change in Deffered Taxes
(4)
(4)
(2)
(3)
(2)
5
(12)
(9)
(18)
(22)
(1)
(1)
(1)
4
(1)
(2)
7
2
(5)
(3)
(5)
(6)
11
9
7
7
6
7
6
8
(5)
(2)
(1)
1
0
(3)
(3)
(6)
(15)
(15)
(17)
Other Non-Cash Items
5
(2)
(16)
(27)
(26)
(20)
11
13
19
15
(19)
(10)
(12)
(7)
21
21
12
17
19
14
29
12
(5)
(2)
(13)
6
7
9
(3)
(4)
(14)
(18)
(25)
(52)
1
3
18
38
41
21
(1)
Cash Taxes Paid
34
39
23
26
24
16
13
21
20
18
31
24
29
40
28
28
36
29
35
37
28
27
32
30
39
63
21
20
20
5
49
53
54
48
39
39
26
30
27
37
43
Cash Interest Paid
16
19
19
19
19
15
17
18
16
15
11
8
4
7
8
9
13
10
8
7
5
4
5
8
9
9
5
2
2
1
4
6
5
7
6
11
17
21
27
21
27
Change in Working Capital
(13)
(7)
(16)
(19)
(23)
(21)
(10)
(20)
(15)
(11)
(1)
(2)
6
11
(4)
7
(3)
(13)
(15)
(5)
12
(10)
(24)
(20)
(42)
(33)
(12)
(6)
(3)
(17)
4
(1)
(18)
(13)
(43)
(25)
(23)
(17)
(9)
(11)
5
Cash from Operating Activities
51
N/A
55
+9%
32
-42%
35
+10%
31
-12%
41
+33%
73
+79%
55
-25%
68
+24%
67
-1%
68
+1%
78
+15%
80
+3%
89
+11%
86
-4%
101
+18%
109
+8%
112
+3%
136
+22%
155
+13%
170
+10%
137
-19%
110
-20%
107
-3%
80
-26%
128
+61%
150
+17%
168
+12%
166
-1%
155
-6%
165
+6%
165
+0%
140
-15%
122
-13%
145
+19%
157
+8%
193
+23%
201
+4%
180
-11%
162
-10%
138
-15%
Investing Cash Flow
Capital Expenditures
(27)
(30)
(25)
(23)
(21)
(19)
(24)
(24)
(34)
(36)
(40)
(42)
(34)
(41)
(42)
(41)
(45)
(39)
(40)
(46)
(47)
(54)
(44)
(47)
(46)
(42)
(56)
(55)
(55)
(68)
(71)
(77)
(83)
(77)
(76)
(75)
(70)
(66)
(68)
(70)
(71)
Other Items
(77)
(61)
(32)
(28)
(27)
(27)
(36)
(21)
(15)
(14)
(10)
(10)
(15)
(11)
(13)
(9)
(7)
(9)
(7)
(31)
(32)
(29)
(96)
(82)
(79)
(281)
(401)
(393)
(467)
(289)
(93)
(96)
(72)
(53)
(69)
(89)
(55)
(51)
(56)
(31)
(53)
Cash from Investing Activities
(104)
N/A
(92)
+12%
(57)
+37%
(51)
+11%
(49)
+5%
(46)
+6%
(61)
-32%
(44)
+28%
(49)
-10%
(50)
-3%
(49)
+1%
(52)
-6%
(50)
+5%
(52)
-5%
(55)
-6%
(50)
+9%
(52)
-4%
(48)
+7%
(47)
+1%
(77)
-61%
(79)
-4%
(83)
-5%
(139)
-68%
(129)
+8%
(125)
+2%
(323)
-158%
(457)
-41%
(448)
+2%
(522)
-17%
(356)
+32%
(164)
+54%
(173)
-5%
(155)
+10%
(130)
+16%
(145)
-12%
(164)
-12%
(125)
+24%
(117)
+6%
(124)
-6%
(101)
+19%
(123)
-23%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(17)
(25)
(43)
(43)
(33)
(41)
(23)
315
322
338
297
(71)
(71)
(96)
(64)
(34)
(34)
(9)
0
0
0
0
(1)
(15)
Net Issuance of Debt
69
62
41
31
43
21
8
9
4
2
2
(1)
(10)
(18)
(10)
(32)
(34)
(23)
(51)
(12)
(14)
10
118
93
80
32
25
36
181
219
153
140
105
62
19
(31)
(98)
(66)
(50)
22
70
Cash Paid for Dividends
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(17)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(24)
(26)
(26)
(26)
(26)
(26)
(26)
(26)
(26)
(26)
(26)
(26)
(26)
(52)
Other
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(0)
(0)
(0)
0
(0)
(0)
(0)
(1)
(3)
(3)
(3)
(2)
(1)
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(5)
(9)
(5)
(5)
(0)
Cash from Financing Activities
51
N/A
44
-14%
23
-48%
13
-43%
25
+93%
3
-88%
(9)
N/A
(8)
+7%
(14)
-61%
(16)
-19%
(16)
+2%
(18)
-17%
(28)
-49%
(36)
-29%
(28)
+21%
(50)
-79%
(52)
-4%
(58)
-11%
(93)
-62%
(73)
+22%
(82)
-12%
(49)
+40%
50
N/A
42
-15%
368
+773%
328
-11%
338
+3%
308
-9%
83
-73%
122
+46%
30
-75%
50
+65%
45
-10%
2
-95%
(16)
N/A
(57)
-250%
(129)
-124%
(101)
+21%
(81)
+20%
(9)
+89%
3
N/A
Change in Cash
Effect of Foreign Exchange Rates
(1)
(1)
0
1
0
0
0
(0)
(0)
0
0
0
0
(0)
(0)
(0)
(1)
(0)
(1)
(0)
0
0
0
(1)
(1)
(2)
(1)
1
1
1
(0)
0
(0)
1
(0)
(2)
(2)
(2)
(1)
(0)
1
Net Change in Cash
(3)
N/A
7
N/A
(2)
N/A
(2)
-16%
8
N/A
(2)
N/A
4
N/A
2
-33%
6
+150%
1
-77%
3
+93%
7
+170%
3
-53%
1
-62%
3
+101%
1
-73%
4
+486%
6
+39%
(5)
N/A
5
N/A
8
+77%
5
-35%
21
+285%
19
-8%
321
+1 552%
131
-59%
30
-77%
30
+1%
(272)
N/A
(79)
+71%
31
N/A
43
+35%
30
-30%
(6)
N/A
(17)
-204%
(66)
-291%
(62)
+6%
(19)
+69%
(26)
-35%
53
N/A
20
-62%
Free Cash Flow
Free Cash Flow
24
N/A
25
+5%
7
-72%
12
+70%
10
-20%
22
+134%
49
+120%
32
-35%
34
+9%
31
-9%
28
-11%
36
+28%
46
+28%
48
+4%
44
-8%
60
+36%
64
+5%
73
+15%
96
+31%
109
+13%
122
+12%
83
-32%
67
-19%
60
-10%
34
-45%
86
+156%
94
+10%
113
+20%
111
-2%
88
-21%
94
+7%
88
-6%
58
-35%
45
-22%
69
+53%
82
+20%
123
+49%
135
+10%
112
-17%
93
-17%
68
-27%

See Also

Summary
COP intrinsic value, competitors valuation, and company profile.
DCF Valuation
COP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COP stock valuation using valuation multiples.
Wall Street Estimates
COP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.